Trending

Whitepapers

Whitepapers

The changing face of pharmaceutical launches

The changing face of pharmaceutical launches

The industry has experienced a sustained period of change since its blockbuster heyday in the 1990s and continues

X

The changing face of pharmaceutical launches

https://pharmaphorum.com/market-access-2/digital-transforming-pharmaceutical-launches/

Remote HCP engagement – still a struggle for life science companies

Remote HCP engagement – still a struggle for life science companies

Life science companies are failing to achieve their full digital potential, particularly when it comes to the use

X

Remote HCP engagement – still a struggle for life science companies

https://pharmaphorum.com/white-papers/remote-hcps-engagement-life-science/

Medical meetings and what HCPs want

Medical meetings and what HCPs want

The healthcare professional (HCP) meeting landscape is evolving, but even as it adjusts to the demands of the

X

Medical meetings and what HCPs want

https://pharmaphorum.com/whitepapers/medical-meetings-and-what-hcps-want/

Pharma brand strategy: Transforming lives with rich insight

The mighty power of true insight lays in its ability to turn data into a brand strategy that

X

Pharma brand strategy: Transforming lives with rich insight

https://pharmaphorum.com/whitepapers/pharma-brand-strategy-transforming-lives-with-rich-insight/

Standing on the cusp of something great: How real-world data is poised to transform cancer care

Standing on the cusp of something great: How real-world data is poised to transform cancer care

REAL-WORLD EVIDENCE IN ONCOLOGY: Towards Innovative and Affordable Patient Care How can real world evidence (RWE) improve the

X

Standing on the cusp of something great: How real-world data is poised to transform cancer care

https://pharmaphorum.com/whitepapers/standing-cusp-something-great-real-world-data-poised-transform-cancer-care/

Pricing and Market Access Outlook 2018

Pricing and Market Access Outlook 2018

This year’s edition of Pricing and Market Access Outlook, our first as IQVIA, identifies a trend towards models

X

Pricing and Market Access Outlook 2018

https://pharmaphorum.com/whitepapers/pricing-market-access-outlook-2018/

Definitive Guide to Global Transparency Regulations for the Life Sciences

Definitive Guide to Global Transparency Regulations for the Life Sciences

In 2015, Zephyr Health released its first ‘Definitive Guide to Global Life Sciences Transparency Regulations’, outlining the

X

Definitive Guide to Global Transparency Regulations for the Life Sciences

https://pharmaphorum.com/whitepapers/transparency-regulations-life-sciences/

Seizing the potential of commercial outsourcing in the pharmaceutical sector

Seizing the potential of commercial outsourcing in the pharmaceutical sector

The power and potential of outsourcing has long been recognised as a core enabler of business growth. Yet

X

Seizing the potential of commercial outsourcing in the pharmaceutical sector

https://pharmaphorum.com/whitepapers/seizing-potential-commercial-outsourcing-pharmaceutical-sector/

Pricing and market access – facts versus fiction

Pricing and market access – facts versus fiction

‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.

X

Pricing and market access – facts versus fiction

https://pharmaphorum.com/whitepapers/pricing-market-access-facts-versus-fiction/

1 2 3 4 5 >»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com